EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge

Daigo Kasamatsu iD, Etsuko Tanabe, Marie Okubo, Makiko Shimodaira, Yoshio Nakamura

Endocrinology, Diabetes & Metabolism Case Reports · 01.04.2026 · 2026 (2)

DOI: 10.1530/edm-25-0177 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrinology, Diabetes & Metabolism Case Reports, online erschienen am 01.04.2026. Verfasst von Daigo Kasamatsu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the case of a woman in her 70s, a known HTLV-1 carrier with recent-onset Graves’ disease, who developed HTLV-1-associated uveitis (HAU) four weeks after the initiation of methimazole therapy. The diagnosis was established based on characteristic ophthalmologic findings and exclusion of other causes. Her uveitis resolved completely following local steroid injection; however, subsequent management of Graves’ disease proved exceptionally challenging. Both methimazole and propylthiouracil eventually had to be discontinued because of safety concerns, including severe adverse reactions with propylthiouracil (granulocytopenia and hepatotoxicity), necessitating radioactive iodine therapy. During long-term follow-up, she developed Sjögren’s syndrome, illustrating the risk of polyautoimmunity in HTLV-1 carriers. This case highlights a diagnostic pitfall: in HTLV-1-endemic areas, new-onset visual disturbances during antithyroid drug treatment should not automatically be attributed to thyroid-associated ophthalmopathy, and HAU should be included in the differential diagnosis. It also underscores the need for careful monitoring for drug-related complications and the emergence of additional autoimmune disorders in this population. Learning points

Schlagwörter

Stichwörter der Autor:innen

Graves’ diseaseHTLV-1polyautoimmunitythyroid-associated ophthalmopathyuveitis

Autor:innen und Institutionen

ORCID-Profile: Daigo Kasamatsu

Zitieren

APA

Kasamatsu, D., Tanabe, E., Okubo, M., Shimodaira, M., & Nakamura, Y. (2026). HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. Endocrinology, Diabetes & Metabolism Case Reports, 2026(2). https://doi.org/10.1530/edm-25-0177

Vancouver

Kasamatsu D, Tanabe E, Okubo M, Shimodaira M, Nakamura Y. HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. Endocrinology, Diabetes & Metabolism Case Reports. 2026;2026(2). doi:10.1530/edm-25-0177

BibTeX
@article{Kasamatsu2026,
  author = {Kasamatsu, Daigo and Tanabe, Etsuko and Okubo, Marie and Shimodaira, Makiko and Nakamura, Yoshio},
  title = {HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge},
  journal = {Endocrinology, Diabetes & Metabolism Case Reports},
  year = {2026},
  volume = {2026},
  number = {2},
  doi = {10.1530/edm-25-0177}
}
Kostenlos starten →